Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (211-220 of 600) with videos related to

Pageof 60
Sort By:
Annals of the Rheumatic Diseases|September 26, 2015
Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohortVictoria Navarro-Compán, Sofia Ramiro, Robert Landewé, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Prevalence of vitamin D deficiency in rheumatoid arthritis and association with disease activity and cardiovascular risk factors: data from the COMEDRA studyStella Cecchetti, Zuzana Tatar, Pilar Galan, et al.
Rheumatology Advances in Practice|April 17, 2025
Long-term tofacitinib efficacy and safety in psoriatic arthritis with or without prior biologic DMARD exposure: a post hoc analysisDafna D Gladman, Maxime Dougados, Helena Marzo-Ortega, et al.
Clinical and Experimental Rheumatology|December 19, 2022
Changes of anti-citrullinated peptide antibodies titers after biologic treatment in patients with rheumatoid arthritis: a systematic literature review and retrospective studyStéphane Hilliquin, Julia Herrou, Loriane Gutermann, et al.
Annals of the Rheumatic Diseases|September 11, 2010
ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritisMaxime Dougados, Paternotte Simon, Juergen Braun, et al.
Arthritis and Rheumatism|January 11, 2003
Evaluation of the smallest detectable difference in outcome or process variables in ankylosing spondylitisGuy-Robert Auleley, Karima Benbouazza, Anneke Spoorenberg, et al.
The Journal of Rheumatology|August 16, 2015
Evaluation of Health Outcomes with Etanercept Treatment in Patients with Early Nonradiographic Axial SpondyloarthritisMaxime Dougados, Wen-Chan Tsai, Diego L Saaibi, et al.
European Journal of Clinical Pharmacology|September 5, 2020
Doctor's aptitude for switching from innovator etanercept to biosimilar etanercept in inflammatory rheumatic diseases: experience from a single French rheumatology tertiary care centerOmar Al Tabaa, Adrien Etcheto, Sophie Dumas, et al.
Annals of the Rheumatic Diseases|January 30, 2015
Lower education and living in countries with lower wealth are associated with higher disease activity in rheumatoid arthritis: results from the multinational COMORA studyPolina Putrik, Sofia Ramiro, Andras P Keszei, et al.
RMD Open|February 22, 2023
The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritisMaxime Dougados, Peter C Taylor, Clifton O Bingham, et al.
Pageof 60

Showing results (211-220 of 600) with videos related to

Sort By:
Pageof 60
Annals of the Rheumatic Diseases|September 26, 2015
Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohortVictoria Navarro-Compán, Sofia Ramiro, Robert Landewé, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Prevalence of vitamin D deficiency in rheumatoid arthritis and association with disease activity and cardiovascular risk factors: data from the COMEDRA studyStella Cecchetti, Zuzana Tatar, Pilar Galan, et al.
Rheumatology Advances in Practice|April 17, 2025
Long-term tofacitinib efficacy and safety in psoriatic arthritis with or without prior biologic DMARD exposure: a post hoc analysisDafna D Gladman, Maxime Dougados, Helena Marzo-Ortega, et al.
Clinical and Experimental Rheumatology|December 19, 2022
Changes of anti-citrullinated peptide antibodies titers after biologic treatment in patients with rheumatoid arthritis: a systematic literature review and retrospective studyStéphane Hilliquin, Julia Herrou, Loriane Gutermann, et al.
Annals of the Rheumatic Diseases|September 11, 2010
ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritisMaxime Dougados, Paternotte Simon, Juergen Braun, et al.
Arthritis and Rheumatism|January 11, 2003
Evaluation of the smallest detectable difference in outcome or process variables in ankylosing spondylitisGuy-Robert Auleley, Karima Benbouazza, Anneke Spoorenberg, et al.
The Journal of Rheumatology|August 16, 2015
Evaluation of Health Outcomes with Etanercept Treatment in Patients with Early Nonradiographic Axial SpondyloarthritisMaxime Dougados, Wen-Chan Tsai, Diego L Saaibi, et al.
European Journal of Clinical Pharmacology|September 5, 2020
Doctor's aptitude for switching from innovator etanercept to biosimilar etanercept in inflammatory rheumatic diseases: experience from a single French rheumatology tertiary care centerOmar Al Tabaa, Adrien Etcheto, Sophie Dumas, et al.
Annals of the Rheumatic Diseases|January 30, 2015
Lower education and living in countries with lower wealth are associated with higher disease activity in rheumatoid arthritis: results from the multinational COMORA studyPolina Putrik, Sofia Ramiro, Andras P Keszei, et al.
RMD Open|February 22, 2023
The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritisMaxime Dougados, Peter C Taylor, Clifton O Bingham, et al.
Pageof 60